Kevin J. Appelbaum - Dec 20, 2021 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Mark Heinen, Attorney-in-Fact for Kevin J. Appelbaum
Stock symbol
BTTX
Transactions as of
Dec 20, 2021
Transactions value $
$4,600
Form type
4
Date filed
12/22/2021, 05:03 PM
Previous filing
Dec 17, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $4.6K +1K +36.36% $4.60* 3.75K Dec 20, 2021 Direct
holding BTTX Common Stock 2.41M Dec 20, 2021 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are owned directly by Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated May 16, 2020, as amended (the "Trust"), and indirectly by Mr. Appelbaum as trustee of the Trust. Mr. Appelbaum is an officer, director and ten percent owner of the Issuer.